Rationale Use of GLP-1 Receptor Agonists in Patients with Type 1 Diabetes
Author:
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
http://link.springer.com/content/pdf/10.1007/s11892-013-0404-x.pdf
Reference30 articles.
1. McIntyre N, Holdsworth CD, Turner DS. Intestinal factors in the control of insulin secretion. J Clin Endocrinol Metab. 1965;25:1317–24.
2. • Unger J, Parkin CG. Type 2 Diabetes: an expanded view of pathophysiology and therapy. Postgraduate Medicine. 2010;122:145–57. Article summarizes the role multiple physiologic deficits associated with type 2 diabetes and the role of incretin mimetic in correcting GLP-1 resistance.
3. Drucker DJ, Nauck MA. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in T2DM. Lancet. 2006;368:1696–705.
4. Drucker DJ. The biology of incretin hormones. Cell Metab. 2006;3:153–65.
5. • Holst JJ, Vilsboll T, Deacon CF. The incretin system and its role in type 2 diabetes mellitus. Mol Cell Endocrinol. 2009;297:127–36. This is an interesting prelude to future research, as both Drs. Holst and Vilsboll will address the use of GLP-1 receptor agonists in T1DM patients in the next 2–3 years.
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Mechanistic Pathways and Clinical Implications of GLP-1 Receptor Agonists in Type 1 Diabetes Management;International Journal of Molecular Sciences;2024-08-29
2. An Overview of Hypoglycemic Biological Drugs;Structure and Health Effects of Natural Products on Diabetes Mellitus;2021
3. Pharmacotherapy of Children and Adolescents with Type 2 Diabetes Mellitus;Handbook of Experimental Pharmacology;2019
4. Pharmacotherapy of Children and Adolescents with Type 1 Diabetes Mellitus;Handbook of Experimental Pharmacology;2019
5. Adjuvant Pharmacotherapies to Insulin for the Treatment of Type 1 Diabetes;Current Diabetes Reports;2018-08-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3